Alnylam Pharmaceuticals vs Ionis Pharmaceuticals
ALNY and IONS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALNY and IONS compare
Alnylam Pharmaceuticals is the larger company, worth 3.1 times as much as Ionis Pharmaceuticals ($22.1B against $7.2B).
Alnylam Pharmaceuticals scores higher on the StockData Score (7 against 3 for Ionis Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALNY | IONS |
|---|---|---|
| Size and price | ||
| Market cap | $22.1B | $7.2B |
| Share price | $165.00 | $43.52 |
| Change, 1 year | −65.7% | −39.5% |
| Change, 5 years | −11.9% | 29.2% |
| Beta (5Y) | 0.88 | 0.71 |
| Employees | 2,500 | 1,402 |
| StockData Score | ||
| Total score | 7 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 1 (better) | 0 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 8.3× |
| P/B | 6.1× (better) | 16.4× |
| FCF yield | – | −7.8% |
| Fair value | – | $28.12 |
| Margin of safety | – | −54.7% |
| Growth | ||
| Revenue growth (TTM) | – | −7.4% |
| Revenue growth, 5Y average | 49.8% (better) | 5.3% |
| Net income growth (TTM) | 2137% | – |
| Profitability | ||
| Gross margin | – | 98.2% |
| Operating margin | – | −68.0% |
| Net margin | – | −64.7% |
| FCF margin | – | −64.2% |
| Return on equity | 127% (better) | −105% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −31.6× |
| Current ratio | 2.48 | 7.89 (better) |
| Altman Z-score | 2.75 (better) | 0.88 |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 99.8% | 108% |
| Held by insiders | 0.49% | 0.80% |
| Insider net buying, 12 months | −$43.6M (better) | −$123M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 5.8% | 13.7% |
Go deeper
- ALNY stock overview
- ALNY income statement
- ALNY valuation and score
- IONS stock overview
- IONS income statement
- IONS valuation and score
Other comparisons
- ALNY vs BMRN
- ALNY vs INSM
- ALNY vs JAZZ
- ALNY vs REGN
- ALNY vs RPRX
- ALNY vs UTHR
- ARWR vs IONS
- CORT vs IONS
- INSM vs IONS
- IONS vs TGTX
For information only, not investment advice. Check the source filings before relying on any figure.